Egil A Fors1, Harold Sexton, K Gunnar Götestam. 1. Department of Psychiatry and Behavioural Medicine, Norwegian University of Science and Technology (NTNU), PO Box 3008 Lade, NO-7441, Trondheim, Norway. eafors@online.no
Abstract
OBJECTIVE: The effectiveness of an attention distracting and an attention focusing guided imagery as well as the effect of amitriptyline on fibromyalgic pain was studied prospectively. METHODS:Fifty-five women with previously diagnosed fibromyalgia were monitored for daily pain (VAS) in a randomized, controlled clinical trial. One group received relaxation training and guided instruction in "pleasant imagery" (PI) in order to distract from the pain experience (n=17). Another group received relaxation training and attention imagery upon the "active workings of the internal pain control systems", "attention imagery" (AI) (n=21). The control group (CG) received treatment as usual (n=17). Patients were also randomly assigned to 50-mg amitriptyline/day or placebo. Some psychological and socio-demographic variables were also measured initially. The slopes of diary pain ratings over a 4-week period were used as the outcome measures. RESULTS: We found significant differences of the pain-slopes between the three psychological conditions (P=0.0001). The pleasant imagery (P<0.005), but not the attention imagery group's slope, declined significantly when compared with the control group (P>0.05). There was neither a difference between the amitriptyline and placebo slopes (main effects, P=0.98) nor a significant amitriptyline x psychological interaction (P=0.76). CONCLUSION:Pleasant imagery (PI) was an effective intervention in reducing fibromyalgic pain during the 28-day study period. Amitriptyline had no significant advantage over placebo during the study period.
RCT Entities:
OBJECTIVE: The effectiveness of an attention distracting and an attention focusing guided imagery as well as the effect of amitriptyline on fibromyalgic pain was studied prospectively. METHODS: Fifty-five women with previously diagnosed fibromyalgia were monitored for daily pain (VAS) in a randomized, controlled clinical trial. One group received relaxation training and guided instruction in "pleasant imagery" (PI) in order to distract from the pain experience (n=17). Another group received relaxation training and attention imagery upon the "active workings of the internal pain control systems", "attention imagery" (AI) (n=21). The control group (CG) received treatment as usual (n=17). Patients were also randomly assigned to 50-mg amitriptyline/day or placebo. Some psychological and socio-demographic variables were also measured initially. The slopes of diary pain ratings over a 4-week period were used as the outcome measures. RESULTS: We found significant differences of the pain-slopes between the three psychological conditions (P=0.0001). The pleasant imagery (P<0.005), but not the attention imagery group's slope, declined significantly when compared with the control group (P>0.05). There was neither a difference between the amitriptyline and placebo slopes (main effects, P=0.98) nor a significant amitriptyline x psychological interaction (P=0.76). CONCLUSION: Pleasant imagery (PI) was an effective intervention in reducing fibromyalgic pain during the 28-day study period. Amitriptyline had no significant advantage over placebo during the study period.
Authors: Peter R Giacobbi; Meagan E Stabler; Jonathan Stewart; Anna-Marie Jaeschke; Jean L Siebert; George A Kelley Journal: Pain Manag Nurs Date: 2015-07-11 Impact factor: 1.929
Authors: Karin B Jensen; Chantal Berna; Marco L Loggia; Ajay D Wasan; Robert R Edwards; Randy L Gollub Journal: Neurosci Lett Date: 2012-03-14 Impact factor: 3.046
Authors: K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner Journal: Schmerz Date: 2008-06 Impact factor: 1.107
Authors: A Klement; W Häuser; W Brückle; U Eidmann; E Felde; M Herrmann; H Kühn-Becker; M Offenbächer; M Settan; M Schiltenwolf; M von Wachter; W Eich Journal: Schmerz Date: 2008-06 Impact factor: 1.107